0001104659-23-072607.txt : 20230620
0001104659-23-072607.hdr.sgml : 20230620
20230620081654
ACCESSION NUMBER: 0001104659-23-072607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliviero James F III
CENTRAL INDEX KEY: 0001434718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41264
FILM NUMBER: 231023465
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvectis Pharma, Inc.
CENTRAL INDEX KEY: 0001875558
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862405608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
BUSINESS PHONE: 360-837-7232
MAIL ADDRESS:
STREET 1: 1 BRIDGE PLAZA, SUITE 275
CITY: FORT LEE
STATE: NJ
ZIP: 07024
4
1
tm2319007-3_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-16
0
0001875558
Nuvectis Pharma, Inc.
NVCT
0001434718
Oliviero James F III
C/O NUVECTIS PHARMA, INC.,
1 BRIDGE PLAZA, SUITE 275
FORT LEE
NJ
07024
1
0
0
0
0
Common Stock
2023-06-16
4
A
0
18000
0
A
27828
D
The 18,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Oliviero's continued service on the board on such dates.
/s/ James F. Oliviero III
2023-06-20